HIV/AIDS and HCV in prisons: A select annotated bibliography (part 2)

International Journal of Prisoner Health

Volumn 2, Issue 2, 2006, Pages 131-149

  Jürgens, Ralf ^a  

^a NONE   (Canada)

Author keywords

Bleach; Condoms; Education; HCV; HIV; Needle exchange; Prevalence; Prevention; Prison; Rape; Risk behaviours; Testing and counselling; Transmission

Indexed keywords

BLEACHING AGENT; DISINFECTANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONDOM; CONFERENCE PAPER; COUNSELING; DISEASE TRANSMISSION; EPIDEMIC; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HEALTH PROGRAM; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; MEDICAL DOCUMENTATION; NEEDLE; PERSUASIVE COMMUNICATION; PRISON; PUBLICATION; RAPE; SEROPREVALENCE; SEXUAL CRIME; SEXUAL INTERCOURSE; SYRINGE; WORLD HEALTH ORGANIZATION;

EID: 33748853148     PISSN: 17449200     EISSN: 17449219     Source Type: Journal    
DOI: 10.1080/17449200600935786     Document Type: Conference Paper

References (78)

1. Alcabes, P., & Braslow, C. (1988). A cluster of cases of penicillinase-producing Neisseria gonorrhoe in an adolescent detention center. NY State Journal of Medicine, 88, 495-496.
2. Allright, S., Bradley, F., Long, J., Thomton, L., Parry, J.V. (2000). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. British Medical Journal, 321, 78-82.
3. Bird, A., et al. (1993). Study of infection with HIV and related risk factors in young offenders' institutions. British Medical Journal, 307, 228-231.
4. Bobrik, A., Danishevski, K., Eroshina, K., McKee, M. (2005). Prison health in Russia: the larger picture. Journal of Public Health Policy, 26, 30-59.
5. Boutwell, A., & Rich, J.D. (2004). HIV infection behind bars. Clinical Infectious Diseases, 38, 1761-1763.
6. Brewer, T.F., et al. (1988). Transmission of HIV-1 within a statewide prison system. AIDS, 2, 363-367.
7. Butler, T., et al. (1999). Seroprevalence of markers for hepatitis B, C and G in male and female prisoners-NSW, 1996. Australian and New Zealand Journal of Public Health, 23, 377-384.
8. Calzavara, L.M., et al. (2003). Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction, 98, 1257-1265.
9. Canadian HIV/AIDS Legal Network (2006). HIV/AIDS in prisons in central and eastern Europe and the former Soviet Union. Info sheets. Montreal: The Network.
10. Castro, K. et al. (1991). HIV transmission in correctional facilities. Presented at the VIIth International Conference on AIDS, Florence, 16-21 June 1991, p. 314.
11. Centers for Disease Control (1986). Acquired Immunodeficiency Syndrome in correctional facilities: Report of the National Institute of Justice and the American Correctional Association. Morbidity and Mortality Weekly Review, 35, 195-199.
12. Centers for Disease Control and Prevention (2001). Hepatitis B outbreak in a state correctional facility, 2000. Morbidity and Mortality Weekly Report, 50, 529-532.
13. Clarke, J.G., Stein, M.D., Hanna, L., Sobota, M., Rich, J.D. (2001). Active and former injection drug users report of HIV risk behaviours during periods of incarceration. Substance Abuse, 22, 209-216.
14. Cravioto, P., et al. (2003). Patterns of heroin consumption in a jail on the northern Mexican border: barriers to treatment access. Salud Publica de Mexico, 45, 181-190.
15. De Groot, A.S. et al. (1999). Women in prison: The importance of HIV. HEPP News, 2, 1-4.
16. DiCenso, A., Dias, G., & Gahagan, J. (2003). Unlocking our futures: A national study on women, prisons, HIV, and hepatitis C. Toronto: PASAN.
17. Dolan, K., Bijl, M., & White, B. (2004a). HIV education in a Siberian prison colony for drug dependent males. International Journal of Equity in Health, 3, 7.
18. Dolan, K., Kite, B., Black, E., Lowe, J., Agaliotis, M., MacDonald, M., et al. Review of injection drug users and HIV infection in prisons in developing and transitional countries. UN Reference Group on HIV/AIDS Prevention and Care among IDUs in Developing and Transitional Countries-available via http://ndarc.med.unsw.edu.au/ ndarc.nsf/website/Research.current. cp47publications.
19. Dolan, K., & Wodak, A. (1999). HIV transmission in a prison system in an Australian State. Medical Journal of Australia, 171, 14-17.
20. Dolan, K., Wodak, A., Hall, W., & Kaplan, E. (1998). A mathematical model of HIV transmission in NSW prisons. Drug & Alcohol Dependence, 50, 197-202.
21. Dufour, A., et al. (1995). HIV prevalence among inmates of a provincial prison in Quebec City. The Canadian Journal of Infectious Diseases, 6(suppl B), 31B.
22. Edwards, A., Curtis, S., & Sherrard, J. (1999). Survey of risk behaviour and HIV prevalence in an English prison. International Journal of STD & AIDS, 10, 464-466.
23. Elwood Martin, R., et al. (2005). Drug use and risk of bloodborne infections: A survey of female prisoners in British Columbia. Canadian Journal of Public Health, 96, 97-101.
24. Estebanez, P.E., Russell, N.K., Aguilar, M.D., Béland F., Zunzunegui, M.V. (2000). Women, drugs and HIV/ AIDS: Results of a multicentre European study. International Journal of Epidemiology, 29, 734-743.
25. Estebanez, P. et al. (1988). Prevalence and risk factors for HIV infection among inmates. IVth International Conference on AIDS. Abstract no 4202.
26. Ford, P.M., et al. (2000). HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Quarterly Journal of Medicine, 93, 113-119.
27. Frost, L., & Tchertkov, V. (2002). Prisoner risk taking in the Russian Federation. AIDS Eduction and Prevention, 14, 7-23.
28. Gaughwin, M.D., Douglas, R.M., & Wodak, A.D. (1991). Behind bars - risk behaviours for HIV transmission in prisons, a review. In: J. Norberry, S.A. Gerull & M.D. Gaughwin (eds). HIV/AIDS and Prisons (conference proceedings). Canberra: Australian Institute of Criminology.
29. Gauney, W., & Gido, R. (1986). AIDS: a demographic profile of New York State inmates. Mortalities 1981-1985. New York: New York State Commission of Correction.
30. Gore, S.M., et al. (1995). Drug injection and HIV prevalence in inmates of Glenochil Prison. British Medical Journal, 310, 293-296.
31. Haber, P.S., et al. (1999). Transmission of hepatitis C within Australian prisons. Medical Journal of Australia, 171, 31-33.
32. Hanrahan, J.P., et al. (1982). Opportunistic infections in prisoners [letter]. New England Journal of Medicine, 307, 498.
33. Health Canada - Public Health Agency of Canada (2004). Hepatitis C virus transmission in the prison/inmate population. Canada Communicable Disease Report, 30, 141-148.
34. Hellard, M., & Aitken, C. (2004). HIV in prison: what are the risks and what can be done? Sexual Health, 1, 107-113.
35. Hogan, N. (1994). HIV education for inmates: Uncovering strategies for program selection. The Prison Journal, 74, 220-243.
36. Horsburgh, C.R., Jarvis, J.Q., MacArthur, T., Ignacio, T., & Stock, P. (1990). Seroconversion to Human Immunodeficiency virus in prison inmates. American Journal of Public Health, 80, 209-210.
37. Jürgens, R. (2006). HIV/AIDS and HCV in prisons: A select annotated bibliography (part 1). International Journal of Prisoner Health, 2, 21-34.
38. Kelley, P.W., et al. (1986). Prevalence and incidence of HTLV-111 infection in a prison. Journal of the American Medical Association, 256, 2198-2199.
39. Krebs, C.P., Simmons, M. (2002). Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who it at risk. AIDS Education and Prevention, 14, 53-64.
40. Koulierakis, et al. (1999). Injecting drug use amongst inmates in Greek prisons. Addiction Research, 7, 193-212.
41. Lines, R., Jürgens, R., Betteridge, G., Stöver, H. (2005). Taking action to reduce injecting drug-related harms in prisons: The evidence of effectiveness of prison needle exchange in six countries. International Journal of Prisoner Health, 1, 49-64.
42. Macalino, G.E., Hou, J.C., Kumar, M.S., Taylor, L.E., Sumantera, I.G., Rich, J.D. (2004a). Hepatitis C infection and incarcerated populations. International Journal of Drug Policy, 15, 103-114.
43. Macalino, G.E., Vlahov, D., Sanford-Colby, S., Patel, S., Sabin, K., Salas, C., et al. (2004b). Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infection among males in Rhode Island prisons. American Journal of Public Health, 94, 1218-1223.
44. MacDonald, M. (2005). A Study of Health Care Provision, Existing Drug Services and Strategies Operating in Prisons in Ten Countries from Central and Eastern Europe. Finland: Heuni.
45. Malliori, M., et al. (1998). A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction, 93, 243-251.
46. Martin, R., et al. (1995). A content assessment and comparative analysis of prison-based AIDS education programs for inmates. Prison Journal, 75, 5-48.
47. Martin, V., et al. (1998). Predictive factors of HIV-infection in injecting drug users upon incarceration. European Journal of Epidemiology, 14, 327-331.
48. Maruschak, L. (2005). HIV in Prisons, 2003. Washington, DC: US Dept of Justice, Bureau of Justice Statistics Bulletin.
49. Medley, G., Dolan, K.A., & Stimson, G. (1992). A model of HIV transmission by syringe sharing in English prisons using surveys of injecting drug users. Presented at the VIIIth International Conference on AIDS, Amsterdam, abstract no MoD 0038, p. 75.
50. Mutter, R.C., Grimes, R.M., & Labarthe, D. (1994). Evidence of intraprison spread of HIV infection. Archives of Internal Medicine, 154, 793-795.
51. O'Sullivan, B., et al. (2003). Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons. Medical Journal of Australia, 178, 546-549.
52. Pintilei, L. (2005). Harm reduction in prisons of Republic of Moldova. Presentation at "HIV/AIDS in Prisons in Ukraine - From Evidence to Action: Prevention and Care, Treatment, and Support." Kiev, 1-2 November.
53. Post, J., et al. (2001). Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Medical Journal of Australia, 174, 183-184.
54. Puisis, M., Levine, W., & Mertz, K. (1998). Overview of sexually transmitted diseases. In M. Puisis (Ed). Correctional Medicine (pp. 127-140). St. Louis, Missouri: Mosby.
55. Rapid Situation Assessment Mauritius (2005). Unpublished paper on file with author.
56. Reindollar, R.W. (1999). Hepatitis C and the correctional population. American Journal of Medicine, 107, 100S-103S.
57. Rich, J.D., et al. (1999). Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. Journal of Acquired Immune Deficiency Syndrome, 22, 161-166.
58. Rosen, H.R. (1997). Acquisition of hepatitis C by a conjunctival splash. American Journal of Infection Control, 9, 566-569.
59. Rotily, M., et al. (2001). Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. European Journal of Public Health, 11, 243-250.
60. Shewan, D., Gemmell, M., & Davies, J.B. (1994). Behavioural change amongst drug injectors in Scottish prisons. Social Science & Medicine, 39, 1585-1586.
61. Singh, S., Prasad, R., & Mohanty, A. (1999). High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. International Journal of STD & AIDS, 10, 475-478.
62. Small, W., et al. (2005). Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Substance Use & Misuse, 40, 831-843.
63. Smith, W.H. (1965). Syphilis epidemic in a southern prison. Journal of the Medical Association of the State of Alabama, 35, 392-394.
64. Spaulding, A., et al. (2002). Human immunodeficiency virus in correctional facilities: a review. Clinical Infectious Diseases, 35, 305-312.
65. Taylor, A., Goldberg, D., Emslie, J., Wrench, J., Gruer, L., Cameron, S., et al. (1995). Outbreak of HIV infection in a Scottish prison. British Medical Journal, 310, 289-292.
66. Thaisri, H., et al. (2003). HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infectious Diseases, 3, 25.
67. Tsang, T., Horowitz, E., & Vugia, D. (2001). Transmission of hepatitis C through tattooing in a United States prison. American Journal of Gastroenterology, 96, 1304-1305.
68. Van Haastrecht, H., Anneke, J.S., & Van Den Hoek, A.R. (1998). High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction, 93, 1417-1425.
69. Van Hoeven, K.H., Rooney, W.C., & Joseph, S.C. (1990). Evidence of gonococcal transmission within a correctional system. American Journal of Public Health, 80, 1505-1506.
70. Vlahov, D., et al. (1991). Prevalence of antibody to HIV-1 among entrants to US correctional facilities. Journal of the American Medical Association, 265, 1129-1132.
71. Vlahov, D., et al. (1993). Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. European Journal of Epidemiology, 5, 566-569.
72. Wolfe, M.I., Xu, F., Patel, P., O'Cain, M., Schillinger, J.A., St. Louis, M.E., Finelli, L. (2001). An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. American Journal of Public Health, 91, 1220-1225.
73. World Health Organization (2002). Hepatitis C. Geneva: WHO.
74. World Health Organization Europe (2005). Status paper on prisons, drugs and harm reduction. Copenhagen: WHO Europe.
75. World Health Organization (2006a). Evidence for Action Technical Papers: Effectiveness of Interventions to Manage HIV/AIDS in Prison Settings. Geneva: WHO.
76. World Health Organization (2006b). Evidence for Action Technical Papers: Effectiveness of Interventions to Manage HIV/AIDS in Prison Settings-Needle and Syringe Programmes and Bleach. Geneva: WHO.
77. Zachariah, R., et al. (2002). Sexually transmitted infections among prison inmates in a rural district of Malawi. Transactions of the Royal Social of Tropical Medicine and Hygiene, 96, 617-619.
78. Zamani, S., et al. (2005). Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centres in Tehran, Iran. AIDS, 19, 709-716.